Impact of Six-Week Bright Light and Exercise Program on Sleep, Symptoms, and Quality of Life in Lung and Esophageal Cancer Patients
Led by Taipei Veterans General Hospital, Taiwan · Updated on 2026-02-17
200
Participants Needed
2
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This research aims to evaluate the effects of a six-week bright-light exposure combined with a specific exercise training program on patients with lung and esophageal cancer. The study focuses on improving sleep-wake rhythm, physical and mental symptoms, quality of life, and assessing one-year recurrence and survival rates. It is a randomized, double-blind clinical trial conducted at a single center in Taiwan involving participants with thoracic cancer.
Participants are randomly assigned to one of two groups. The experimental group undergoes a rehabilitation program consisting of daily morning bright-light exposure for 36 minutes and tailored moderate-intensity walking sessions three times per week for six weeks, with weekly exercise consultations via a communication app. The control group participates in a six-week stretching exercise program involving four movements, lasting 10 minutes per session, three times a week. Both groups receive instruction through manuals, videos, and online resources.
During the study, participants will be assessed five times before the intervention, at the 6th and 12th weeks, and at the 6th and 12th months. Researchers will measure sleep-wake rhythm changes, subjective and objective sleep quality, anxiety and depression levels, quality of life, and track cancer recurrence and survival rates. The study includes long-term follow-up to evaluate outcomes over one year.
CONDITIONS
Brief Title
Effects of Bright-light Exposure Combined With Specific Exercise Training (BEST) Program in Patients With Cancer
Research Team
H
Hui-Mei Chen, PhD
M
Mei-Fen Dai, MSN
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
National Taipei University of Nursing and Health Sciences
Collaborating Sponsor
Who Can Participate
Age: 20Years +
All Genders
Eligibility Criteria
You may qualify if you...
Patients with newly diagnosed primary lung cancer or esophageal cancer, from the first stage to the third stage.
At least 20 years of age.
Able to communicate in Mandarin Chinese or Taiwanese.
Literate and free from cognitive disabilities.
The attending physician agrees to participate in the study.
Those who can connect to the Internet with mobile devices such as computers, mobile phones, and tablets, or those whose family members can assist in the operation.
Those with Karnofsky Performance Scale (KPS) greater than or equal to 70 points.
Those who are hospitalized for lung cancer or esophageal cancer lesion resection.
You will not qualify if you...
Congestive heart failure.
Orthopedic diseases of the lower extremities that limit one's walking ability.
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening and enrollment visit
Outpatient Treatment
Duration - 6 weeks
Participants receive a six-week program of bright-light exposure combined with specific exercise training or a six-week stretching exercise program to support their physical and psychological health.
Weekly exercise consultations via communication software and daily or thrice weekly exercise sessions depending on group assignment
Long-term Monitoring
Duration - Up to 12 months
Participants are monitored for sleep-wake rhythm, physical and psychological symptoms, quality of life, recurrence, and survival over one year following the intervention.
Assessments at 6th week, 12th week, 6th month, and 12th month
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Similar Trials
Phase III Study of UCB4594, a Monoclonal Antibody Targeting HLA-G, Alone and With Other Cancer Treatments in Adults With Advanced Solid Tumors
Phase 12 Study of STAR0602, a Targeted T Cell Receptor Antibody Treatment, in Adults with Advanced or Metastatic Solid Tumors That Are Antigen-rich
Evaluating LY4257496 Radioligand Therapy in Adults With GRPR-Positive Advanced Solid Tumors Including Breast, Colorectal, and Prostate Cancer
Dose Escalation and Optimization of LY4337713 Radioligand Therapy for Adults with FAP-Positive Solid Tumors
Phase II Study of Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection as Postoperative Therapy for Esophageal Squamous Cell Carcinoma
Study to Find New RNA Biomarkers in Blood for Early Detection of Barretts Esophagus and Esophageal Adenocarcinoma
Phase II Study of Camrelizumab with Chemoradiotherapy for Advanced Esophageal Squamous Cell Carcinoma in Patients Aged 18 to 75
Multicenter Study Evaluating New Surgery and Care Approaches
for Lung Cancer in Patients 65 and Older
Including Perioperative Treatment and Rehabilitation
Comparing Fully Covered and Partially Covered Esophageal Stents to Relieve Swallowing Difficulties in Esophageal Cancer Patients
Randomized Trial Comparing 0.4% Hyaluronic Acid and Hydroxyethylamide Solutions for Early Esophageal Cancer Submucosal Endoscopic Resection
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Effects of Rehabilitation Program on Quality of Life, Sleep, Rest-Activity Rhythms, Anxiety, and Depression of Patients With Esophageal Cancer: A Pilot Randomized Controlled Trial.
Relationships Among Physical Activity, Daylight Exposure, and Rest-Activity Circadian Rhythm in Patients With Esophageal and Gastric Cancer: An Exploratory Study.
Randomised controlled trial on the effectiveness of home-based walking exercise on anxiety, depression and cancer-related symptoms in patients with lung cancer.